EP 2844067 A1 20150311 - ORAL TABLET FORMULATION CONSISTING OF IMMEDIATE RELEASE ROSUV ASTATIN AND EXTENDED RELEASE METFORMIN
Title (en)
ORAL TABLET FORMULATION CONSISTING OF IMMEDIATE RELEASE ROSUV ASTATIN AND EXTENDED RELEASE METFORMIN
Title (de)
ORALE TABLETTENFORMULIERUNG AUS ROSUV ASTATIN MIT UNMITTELBARER FREISETZUNG UND METFORMIN MIT VERZÖGERTER FREISETZUNG
Title (fr)
FORMULATION DE COMPRIMÉ ORAL CONSTITUÉE DE ROSUVASTATINE À LIBÉRATION IMMÉDIATE ET DE METFORMINE À LIBÉRATION PROLONGÉE
Publication
Application
Priority
- US 201261612563 P 20120319
- US 201261640971 P 20120501
- US 2013031986 W 20130315
Abstract (en)
[origin: WO2013142314A1] The present invention is directed to solid dosage product and formulation containing a fixed combination of rosuvastatin and metformin such that rosuvastatin is delivered immediately to the patient and metformin is delivered in a controlled fashion over a longer course of time, also described as extended release, as well as to methods of making such solid dosage forms and method of treating patients with fixed combination solid dosage forms of immediate release rosuvastatin and extended release metformin.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/155 (2006.01); A61K 31/505 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01)
CPC (source: EP)
A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/2086 (2013.01); A61K 31/155 (2013.01); A61K 31/505 (2013.01); A61P 3/06 (2017.12); A61P 3/10 (2017.12)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2013142314 A1 20130926; EP 2844067 A1 20150311; EP 2844067 A4 20151125; MX 2014011167 A 20141114
DOCDB simple family (application)
US 2013031986 W 20130315; EP 13765204 A 20130315; MX 2014011167 A 20130315